We are live on ! Find out more
AGA

Altrinsic Global Advisors Portfolio holdings

AUM $2.79B
1-Year Est. Return 7.25%
This Fund
S&P 500
This Quarter Est. Return
+0.49%
1 Year Est. Return
+7.25%
3 Year Est. Return
+44.27%
5 Year Est. Return
+55.25%
10 Year Est. Return
+173.46%
AUM
$2.16B
AUM Growth
-$7.72M
Cap. Flow
+$7.49M
Cap. Flow %
0.35%
Top 10 Hldgs %
58.86%
Holding
86
New
4
Increased
19
Reduced
36
Closed
6

Top Buys

Rank Stock Value
1
CTSH icon
Cognizant
CTSH
+$36.5M
2
MDT icon
Medtronic
MDT
+$35.2M
3
VOD icon
Vodafone
VOD
+$34.8M
4
AAP icon
Advance Auto Parts
AAP
+$11.1M
5
JBHT icon
JB Hunt Transport Services
JBHT
+$9.55M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$24M
2
QCOM icon
Qualcomm
QCOM
+$23.7M
3
CB icon
Chubb
CB
+$20.8M
4
WTW icon
Willis Towers Watson
WTW
+$10.1M
5
FDX icon
FedEx
FDX
+$7.33M

Sector Composition

Rank Sector Weight
1 Financials 30.88%
2 Communication Services 19.9%
3 Healthcare 14.13%
4 Technology 8.95%
5 Energy 7.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AKCA
51
DELISTED
Akcea Therapeutics Inc
AKCA
$2.82M 0.13%
120,286
+70,000
+139% +$1.73M
L icon
52
Loews
L
$24.6B
$2.38M 0.11%
43,472
TS icon
53
Tenaris
TS
$28.1B
$2.33M 0.11%
88,494
VIV icon
54
Telefônica Brasil
VIV
$21B
$2.18M 0.1%
167,587
IBN icon
55
ICICI Bank
IBN
$109B
$1.93M 0.09%
153,221
-21,347
-12% -$247K
KURA icon
56
Kura Oncology
KURA
$826M
$1.87M 0.09%
95,000
-10,000
-10% -$166K
SHG icon
57
Shinhan Financial Group
SHG
$32.8B
$1.86M 0.09%
47,773
PRQR icon
58
ProQR Therapeutics
PRQR
$248M
$1.83M 0.08%
201,360
+2,300
+1% +$27.1K
XENE icon
59
Xenon Pharmaceuticals
XENE
$6.28B
$1.77M 0.08%
180,000
+20,000
+13% +$191K
EHC icon
60
Encompass Health
EHC
$11.5B
$1.76M 0.08%
34,996
ELGX
61
DELISTED
Endologix Inc
ELGX
$1.74M 0.08%
240,000
+110,000
+85% +$750K
ARA
62
DELISTED
American Renal Associates Holdings, Inc
ARA
$1.64M 0.08%
220,000
CFMS
63
DELISTED
Conformis, Inc. Common Stock
CFMS
$1.54M 0.07%
14,158
-5,000
-26% -$412K
CSCO icon
64
Cisco
CSCO
$456B
$1.53M 0.07%
28,040
FTSV
65
DELISTED
Forty Seven, Inc. Common Stock
FTSV
$1.48M 0.07%
140,000
+118,043
+538% +$1.73M
FATE icon
66
Fate Therapeutics
FATE
$270M
$1.42M 0.07%
70,000
DRNA
67
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$1.42M 0.07%
90,000
DVCR
68
DELISTED
Diversicare Healthcare Services Inc
DVCR
$1.4M 0.06%
373,952
VYGR icon
69
Voyager Therapeutics
VYGR
$184M
$1.36M 0.06%
50,000
-139,927
-74% -$3.2M
CNDT icon
70
Conduent
CNDT
$251M
$1.33M 0.06%
138,576
-628,331
-82% -$6.79M
NTES icon
71
NetEase
NTES
$81.5B
$1.29M 0.06%
25,220
-11,045
-30% -$586K
AAC
72
DELISTED
AAC Holdings
AAC
$1.25M 0.06%
1,455,718
+281,348
+24% +$394K
JOYY
73
JOYY Inc
JOYY
$3.77B
$1.16M 0.05%
16,690
+10,180
+156% +$777K
AGTC
74
DELISTED
Applied Genetic Technologies Corporation
AGTC
$1.16M 0.05%
306,900
VIPS icon
75
Vipshop
VIPS
$7.13B
$1.08M 0.05%
125,615

Similar funds

Altrinsic Global Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Altrinsic Global Advisors held 86 positions worth $2.16B, down 0.36% from $2.17B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Altrinsic Global Advisors's Q2 2019 filing shows 4 new, 19 increased, 36 reduced and 6 closed positions. Its largest new stake was JB Hunt Transport Services: 101,162 shares worth $9.25M. The largest sale was PepsiCo, an estimated $24M.

By sector, the portfolio is most concentrated in Financials at 31% of assets, up from 30% a quarter earlier, followed by Communication Services and Healthcare.

  • Altrinsic Global Advisors's largest Q2 2019 buy was JB Hunt Transport Services: 101,162 shares worth $9.25M.
  • Altrinsic Global Advisors added most to Cognizant in Q2 2019, an estimated $36.5M increase.
  • Altrinsic Global Advisors's biggest Q2 2019 reduction was PepsiCo, cutting an estimated $24M.
  • Altrinsic Global Advisors fully exited Qualcomm in Q2 2019, selling an estimated $23.7M.
  • Altrinsic Global Advisors's ten largest holdings make up 59% of its $2.16B portfolio in Q2 2019.
  • Altrinsic Global Advisors opened 4 new positions and closed 6 in Q2 2019.
  • Altrinsic Global Advisors's portfolio value fell 0.36% quarter-over-quarter to $2.16B.

Based on Altrinsic Global Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.